Possible Alzheimer’s Drug Advancements; Bernard-Henri Lévy On Syria

Biotech company Biogen has announced plans to seek experimental approval for an Alzheimer's drug that appeared to fail in clinical trials earlier this year. STAT reporter Sharon Begley has the latest. Also, French philosopher Bernard-Henri Lévy, a vocal advocate for the Kurds, discusses the recent developments in Syria. That and more, in hour one of Here & Now's October 23, 2019, full broadcast. You can find more at hereandnow.org, follow us on Twitter and join the conversation on Facebook.